###begin article-title 0
###xml 92 97 <span type="species:ncbi:9606">human</span>
Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy
###end article-title 0
###begin p 1
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 1
###begin p 2
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background.</bold>
###xml 250 257 244 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 262 270 256 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Background. Activation of the thrombospondin-1 (TSP-1)-TGF-beta pathway by glucose and the relevance of TSP-1-dependent activation of TGF-beta for renal matrix expansion, renal fibrosis and sclerosis have previously been demonstrated by our group in in vivo and in vitro studies.
###end p 2
###begin p 3
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Design and methods.</bold>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Design and methods. We investigated renal biopsies (n = 40) and clinical data (n = 30) of patients with diabetic nephropathy. Ten kidneys without evidence of renal disease served as controls. Glomerular and cortical expression of TSP-1, p-smad2/3, fibrosis and glomerular sclerosis (PAS) were assessed by immunhistochemical staining and related with clinical data.
###end p 3
###begin p 4
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results.</bold>
###xml 309 310 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 469 470 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 482 483 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 491 492 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 555 556 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 565 566 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Results. Glomerular (g) and cortical (c) TSP-1 were increased during diabetic nephropathy (g: 2.62 +/- 2.65; c: 4.5 +/- 4.2) compared to controls (g: 0.67 +/- 0.7; c: 1.5 +/- 1.2). P-smad2/3 was significantly increased (g: 16.7 +/- 12.9; c: 148.7 +/- 92.8) compared to controls (g: 7.1 +/- 3.6; c: 55 +/- 25; P < 0.05). TSP-1 was coexpressed with p-smad2/3 as an indicator of TGF-beta activation. TSP-1 correlated with enhanced tubulointerstitial p-smad2/3 positivity (r = 0.39 and r = 0.4, P < 0.05) and glomerular p-smad2/3 correlated with proteinuria (r = 0.35, P < 0.05).
###end p 4
###begin p 5
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions.</bold>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
Conclusions. In summary, the present study suggests a functional activity of the TSP-1/TGF-beta axis, especially in the tubulointerstitium of patients with diabetic nephropathy. The positive correlation of glomerular p-smad2/3 positivity with proteinuria further supports the importance of the TSP-1/TGF-beta system as a relevant mechanism for progression of human type-2 diabetic nephropathy.
###end p 5
###begin title 6
Keywords
###end title 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 525 528 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3 R4">3,4</xref>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Diabetic nephropathy is the number one cause of end-stage renal failure in the western world [1]. Despite a steadily increasing number of diabetic patients, there exist few concepts to prevent disease progression and overt renal failure [2]. While predominant changes during early diabetic nephropathy include altered haemodynamics, hyperfiltration and hyperglycaemia, progressive glomerulosclerosis with the presence of Kimmelstiel-Wilson lesions and tubulointerstitial fibrosis can be found during later stages of disease [3,4].
###end p 8
###begin p 9
###xml 163 164 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 384 387 375 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6 R7">6,7</xref>
TGF-beta is considered the central cytokine for the development of diabetic nephropathy mediating glomerular hypertrophy, matrix expansion and glomerulosclerosis [5]. After its extracellular activation, TGF-beta binds to the specific receptors TGF-beta-R1 and -R2 mediating phosphorylation of transcription signalling molecules (p-smads) and subsequent transcription of target genes [6,7].
###end p 9
###begin p 10
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8 R9 R10">8&#8211;10</xref>
###xml 344 352 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 357 364 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 384 389 381 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11 R12">11,12</xref>
###xml 406 411 403 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13 R14 R15">13&#8211;15</xref>
###xml 703 710 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 712 714 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 800 805 <span type="species:ncbi:9606">human</span>
Thrombospondin-1 (TSP-1) is the founding member of a family of matricellular glycoproteins [8]. While predominantly in vitro studies have assigned diverse functions such as phagocytosis, adhesion, chemotaxis, proliferation and migration of cells to TSP-1 [8-10], it has also been identified as an activator of the TGF-beta-procytokine complex. In vitro and in vivo studies by others [11,12] and our group [13-15] have shown that TSP-1 binds to the latent TGF-beta-procytokine complex causing a conformational change and acting as an endogenous activator of TGF-beta in inflammatory disease. Since we recently established TSP-1 as an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo [15], this study aimed to examine the potential relevance of the TSP-1/TGF-beta axis for human type-2 diabetic nephropathy.
###end p 10
###begin p 11
###xml 173 181 <span type="species:ncbi:9606">patients</span>
In the present study, we evaluated the spatial relationship of glomerular as well tubulointerstitial expression of TSP-1 and subsequent TGF-beta signalling in biopsies from patients with type-2 diabetic nephropathy and correlated these biopsy data with each other and with clinical data of disease progression.
###end p 11
###begin title 12
Material and methods
###end title 12
###begin title 13
Source of tissue
###end title 13
###begin p 14
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
Archival tissues from core needle biopsies performed between 1992 and 2003 at the Klinikum Nuremberg (Nuremberg, Germany) were used for this study (n = 40). The morphological diagnosis of diabetic nephropathy was made by the local pathologist unaware of study findings. Each diagnosis was confirmed by the past medical history of diabetes, thereby excluding patients with type 1 diabetes. Control tissues without evidence of renal disease (n = 10) were obtained from distant portions of kidneys surgically excised because of the presence of a localized neoplasm.
###end p 14
###begin title 15
Tissue processing and immunohistochemical staining
###end title 15
###begin p 16
###xml 345 351 <span type="species:ncbi:10090">murine</span>
###xml 355 361 <span type="species:ncbi:9986">rabbit</span>
###xml 376 382 <span type="species:ncbi:9986">rabbit</span>
###xml 388 393 <span type="species:ncbi:10090">mouse</span>
###xml 437 441 <span type="species:ncbi:9925">goat</span>
###xml 447 453 <span type="species:ncbi:9986">rabbit</span>
All biopsies were fixed in 3% paraformaldehyde, embedded in paraffine, and cut into 4 mum sections for indirect immunoperoxidase staining according to standard protocols. Negative controls for immunostaining included either deletion of the primary antibody or substitution of the primary antibody with equivalent concentrations of an irrelevant murine or rabbit mAb. Specific rabbit anti-mouse and (all DakoCytomation, Hamburg, Germany) goat anti-rabbit POD-conjugated (Dianova, Hamburg, Germany) secondary antibodies were applied followed by colour development with AEC (3-amino-9-ethylcarbazole; DakoCytomation), a ready-to-use substrate chromogen.
###end p 16
###begin p 17
To perform immunoperoxidase staining, tissue sections were incubated with the following primary and secondary antibodies as indicated at 4degreesC overnight.
###end p 17
###begin title 18
Antibodies used in this study
###end title 18
###begin p 19
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 325 327 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 49 55 <span type="species:ncbi:10090">murine</span>
###xml 111 117 <span type="species:ncbi:9986">rabbit</span>
###xml 245 251 <span type="species:ncbi:9986">rabbit</span>
Antibodies used in this study were Clone A6.1, a murine IgG1 mAb against TSP-1 (Dunn, Asbach, Germany) [15]; a rabbit polyclonal antibody against phosphorylated smad2/3 (p-smad2/3) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) [15] and a rabbit polyclonal antibody against TGF-beta1/2 (Santa Cruz Biotechnology Inc.) [15]. PAS stains were used to evaluate glomerulosclerosis and tubulointerstitial fibrosis.
###end p 19
###begin title 20
Quantitative analysis of immunostaining
###end title 20
###begin p 21
###xml 1446 1447 1443 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
For all stainings, all glomeruli were analysed in a blinded fashion using a 400-fold magnification. Glomerular and cortical TSP-1 were quantified using computer-assisted image analysis software (MetaVue, Visitron Systems, Puchheim, Germany) determining the percentage of area positive for TSP-1. Glomerular and tubulointerstitial expression of TGF-beta1/2 were evaluated using a semiquantitative scoring system from 0 to 4, where 0 means <5%, 1 means 6-25%, 2 means 26-50%, 3 means 51-75% and 4 means 76-100% positively stained area per glomerular cross section or tubulointerstitial field of vision, respectively. Assessment of glomerulosclerosis was done via PAS stainings. A semiquantitative scoring system from 0 to 4 was applied where 0 means no sclerosis and 1 means 0-25%, 2 means 26-50%, 3 means 51-75% and 4 means 76-100% of the glomerular tuft area is sclerotic. Fibrosis was assessed on PAS-stained tissues using a semiquantitative scoring system from 0 to 3, where 0 means absence of fibrosis, 1 means 0-25%, 2 means 26-50% and 3 means >50% of fibrotic area. All findings were compared to glomeruli from kidneys without evidence of renal disease. For every biopsy the local nephropathologist evaluated the severity of diabetic nephropathy in a blinded fashion. Thereby, each biopsy was semiquantitatively graded according to the degree of glomerulosclerosis, tubulointerstitial fibrosis and inflammation from 1 to 3 as shown in Table 1 that described the semiquantitative grade of morphology in diabetic nephropathy.
###end p 21
###begin p 22
Scoring system for the assessment of diabetic nephropathy
###end p 22
###begin title 23
Immunohistochemical and fluorescence double staining
###end title 23
###begin p 24
Double staining for TSP-1/p-smad2/3 was performed by co-incubation of TSP-1 and p-smad2/3 antibodies followed by different specific Alexa-Fluor antibodies.
###end p 24
###begin title 25
Clinical records
###end title 25
###begin p 26
###xml 64 72 <span type="species:ncbi:9606">patients</span>
At the day of biopsy the following data were collected from the patients corresponding to their clinical record: age, duration of diabetes, proteinuria, albuminuria, presence of retinopathy, presence of diabetic neuropathy, presence duration of hypertension, HbA1c level, serum creatinine and urea.
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 360 361 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 411 412 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 455 456 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 640 641 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
All values were expressed as mean +/- SD. Statistical calculations were done using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA). In the first step all data were analysed using the Kolmogorov-Smirnov test to test for normal distribution of all parameters. For normally distributed data, statistical significance (defined as a P-value of <0.05) was evaluated using the unpaired t-test followed by an analysis of variance (F-test) and in the case of statistically significant differences regarding variances the Welch-test was used to verify differences of data. For non-parametric testing, the Mann-Whitney U-test was applied. Correlations were calculated using Spearman's algorithm.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Glomerular and cortical TSP-1 as well as TGF-ss expression are increased during diabetic nephropathy
###end title 30
###begin p 31
###xml 102 103 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 236 237 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 434 435 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 451 452 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 712 713 700 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 844 845 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 860 861 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1078 1079 1066 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1089 1090 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1317 1318 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1376 1377 1362 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1391 1392 1377 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1417 1418 1403 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1481 1482 1467 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1912 1913 1890 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1916 1917 1894 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1998 1999 1976 1977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
In control kidneys, TSP-1 staining was absent in most glomeruli (0.67 +/- 0.68% positive area; Figure 1A) and present only in small amounts predominantly in some tubules within the tubulointerstitium (1.4 +/- 1.2% positive area, Figure 1B). Glomerular (2.62 +/- 2.65% positive area) as well as cortical (4.5 +/- 4.2% positive area; mainly consisting of tubulointerstitial) TSP-1 was increased in diabetic versus control kidneys (both P < 0.05; Figure 1C, D). Differentiation of diabetic nephropathy in three stages of severity demonstrates that in milder diabetic lesions, glomerular and tubulointerstitial, an increase of TSP-1 can be seen (stage 1: 1.98 +/- 1.98, stage 2: 1.47 +/- 1.94% positive area, Figure 1E-G), but did not reach statistical significance compared to controls due to the low number of biopsies for these groups (stage 1: n = 5, stage 2: n = 5) and a significant variation of diabetic disease and TSP-1 expression in individual glomeruli within the same biopsy. Nevertheless, among all biopsies, glomerular TSP-1 expression correlated with disease stages (r = 0.392, P < 0.05). In kidneys with enhanced diabetic disease, glomeruli demonstrated most prominent TSP-1 expression in various cell types such as mesangial, endothelial and inflammatory cells (stage 3: 3 +/- 2.9% positive area; Figure 1E, H-J), which reached statistical significance (stage 3, n = 30, Figure 1E) compared to controls (P < 0.05). In glomeruli with Kimmelstiel-Wilson lesions (Figure 1J), TSP-1 expression could be found at the exterior of these lesions, while the acellular nodules were usually devoid of any TSP-1. In parallel, increased TSP-1 within the cortex, predominantly reflecting tubulointerstitial expression, was most prominent in kidneys with advanced disease (stage 1: 5.7 +/- 4.4, stage 2: 3.9 +/- 6.1, stage 3: 4.4 +/- 3.9% positive area) compared to controls (1.49 +/- 1.2 5% positive area, Figure 1F, P < 0.05) and could be localized mainly to inflammatory cells and tubules (Figure 1H).
###end p 31
###begin p 32
###xml 166 167 166 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 206 207 206 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 222 223 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 239 240 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 447 448 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 464 465 464 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 553 554 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 654 655 654 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 657 658 657 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 762 763 762 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 765 766 765 766 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 837 838 837 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 841 842 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 842 843 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
TSP-1 expression is enhanced during type-2 diabetic nephropathy. Immunohistochemistry of TSP-1 in normal kidneys demonstrated the wide absence of TSP-1 in glomeruli (A) but some low level TSP-1 in tubules (B). Glomerular (C) and cortical (D; representing mainly tubulointerstitial) TSP-1 expression were evaluated as described in the Material and methods section and were increased in type-2 diabetic nephropathy. Expression levels of glomerular (E) and cortical (F) TSP-1 varied among biopsies with different severity of lesions. With ongoing disease (G) TSP-1 expression within glomeruli could be detected in various glomerular and inflammatory cells (H, I). In the tubulointerstitium, TSP-1 was mainly confined to tubules and inflammatory interstitial cells (G, H). Kimmelstiel-Wilson lesions demonstrated a typical staining pattern (J) (*P < 0.05 by the Mann-Whitney U-test).
###end p 32
###begin p 33
###xml 102 103 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 118 119 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 134 135 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 150 151 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 256 258 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 259 261 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 390 391 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 403 404 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 421 422 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 522 523 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 535 536 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 553 554 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
In addition, we also evaluated TGF-beta expression in a smaller proportion of renal biopsies (normal: n = 8, stage 1: n = 4, stage 2: n = 0, stage 3: n = 8) to verify the previously published increase of TGF-beta during diabetic nephropathy in this study [12,16]. Thereby we found significantly increased glomerular [1.1 +/- 0.28 (stage 1) and 1.54 +/- 0.29 (stage 3) versus 0.55 +/- 0.26; P < 0.05 and P < 0.001; Figure 2A] and tubulointerstitial [1.38 +/- 0.18 (stage 1) and 2.0 +/- 0.53 (stage 3) versus 0.75 +/- 0.27; P < 0.05 and P < 0.001; Figure 2B] expression of TGF-beta, as evaluated after staining against TGF-beta1/2.
###end p 33
###begin p 34
###xml 105 106 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 132 133 129 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 454 455 448 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 522 523 516 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 584 585 578 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 587 588 581 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 695 696 689 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 698 699 692 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 708 709 702 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 772 773 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 873 874 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 874 875 868 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 903 904 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 911 912 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 912 913 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 937 938 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Increased TGF-beta expression and p-smad2/3 positivity during advanced diabetic nephropathy. Glomerular (A) and tubulointerstitial (B) immunohistochemistry of TGF-beta-1/2 were evaluated using a semiquantitative scoring system as described in the Material and methods section. Immunohistochemistry of p-smad2/3 was evaluated by counting positive cells in glomeruli and the tubulointerstitium. Glomerular p-smad2/3 was increased in all diabetic biopsies (C) and biopsies with mild (grade 1) and advanced (grade 3) lesions (D) whereas cortical p-smad2/3 was increased in all subgroups (E, F). Double labelling of TSP-1 and p-smad2/3 was performed as described in the Material and methods section (G, H). Panel G and its zoomed areas depict glomerular co-localization; panel H depicts the clear co-localized TSP-1 and p-smad 2/3 in the tubulointerstitium of diabetic kidneys (*P < 0.05 by the Mann-Whitney U-test; #P < 0.05 by the unpaired t-test and Welch-test).
###end p 34
###begin title 35
Increased p-smad2/3 co-localizes and correlates with TSP-1 expression during diabetic nephropathy
###end title 35
###begin p 36
###xml 268 269 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 345 346 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 480 481 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 630 631 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 647 648 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 737 738 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
After activation of TGF-beta, TGF-beta receptor signalling led to complexation of smads 2 and 3 and subsequent phosphorylation. Evaluation of p-smad2/3 positive nuclei showed significantly increased positive cell numbers in glomeruli (16. +/- 12.9 versus 7.1 +/- 3.6; P < 0.05) of biopsies with diabetic nephropathy compared to controls (Figure 2C). Hereby, glomerular numbers of p-smad2/3 positive nuclei were similarly increased in all stages of diabetic glomerulopathy (Figure 2D). In parallel, p-smad2/3 positivity was increased threefold in the tubulointerstitium compared to control biopsies (148 +/- 92.8 versus 55 +/- 25; P < 0.05, Figure 2E) and this increase was relatively independent of the stage of disease severity (Figure 2F).
###end p 36
###begin p 37
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
To demonstrate that TSP-1 and p-smad2/3 co-localize in biopsies with diabetic nephropathy, fluorescence double labelling of TSP-1 and p-smad2/3 was performed. Thereby, extracellular TSP-1 and nuclear p-smad2/3 clearly localized next to each other in biopsies with type-2 diabetic nephropathy. Examples of co-localization in glomerular and tubulointerstitial diabetic lesions are depicted in Figure 2G and H. Typical areas are shown as a zoomed image.
###end p 37
###begin title 38
Activity of the tubulointerstitial TGF-beta pathway correlates with the degree of TSP-1 and proteinuria
###end title 38
###begin p 39
###xml 345 346 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
After demonstration of co-localization of TSP-1 and p-smad2/3, we subsequently assessed whether increased TSP-1 expression is directly linked to increased TGF-beta activation as indicated by p-smad2/3. Hereby, both cortical and glomerular TSP-1 expression correlated with the amount of p-smad2/3 positive cells in the tubulointerstitium (Figure 3A and B), while no correlation was detected between glomerular TSP-1 and glomerular p-smad2/3.
###end p 39
###begin p 40
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 379 380 379 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
TSP-1 expression and p-smad2/3 positivity correlate in the tubulointerstitium. Correlations were calculated using Spearman's algorithm. Thereby, cortical TSP-1 (A) and glomerular TSP-1 (B) correlated with p-smad2/3 positivity in the tubulointerstitium. The number of glomerular cells positive for p-smad2/3 also correlated with proteinuria in patients with diabetic nephropathy (C).
###end p 40
###begin p 41
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 512 513 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 1051 1052 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1119 1120 1090 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1389 1390 1360 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 434 442 <span type="species:ncbi:9606">patients</span>
###xml 536 544 <span type="species:ncbi:9606">patients</span>
###xml 692 700 <span type="species:ncbi:9606">patients</span>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
In this study, clinical data from 30 out of 40 patients were available as shown in Table 2. The mean age of patients was 59.35 +/- 13.7 years (versus controls 48.9 +/- 19.3 n.s.). The mean duration of diabetes was 12.97 +/- 8.8 years, and proteinuria 5504 +/- 5372 mg/24 h and albuminuria 2133 +/- 2302 mg/24 h were markedly increased. In parallel, serum creatinine values (300.6 +/- 114.9 mumol/l) indicated advanced disease in most patients. A summary of diabetes-associated complications is depicted in Table 2. Sixty percent of all patients presented with a prior diagnosis of arterial hypertension and received antihypertensive medication before the renal biopsy. Forty-three percent of patients had been put on ACE inhibitor treatment prior to the renal biopsy that had no influence on expression levels of TSP-1 or p-smad2/3 compared to patients without ACE inhibitors [TSP1 glomerular (%): 1.9 +/- 1.1 versus 2.3 +/- 1.2, n.s.; TSP-1 cortical (%): 3.1 +/- 3.9 versus 3.4 +/- 3.2, n.s.; p-smad2/3 glomerular: 13.5 +/- 8.8 versus 18.3 +/- 10.4 (n), n.s.; p-smad2/3 cortical: 118.6 +/- 55.9 versus 128.2 +/- 53.9 (n), n.s.]. Differentiation of baseline data from all three subgroups (grade 1-3) compared to controls demonstrates that functional parameters such as proteinuria and serum creatinine are linked to severity of histological lesions (glomerulosclerosis and fibrosis; Table 3).
###end p 41
###begin p 42
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Baseline parameters of diabetic and non-diabetic patients and presence of diabetic complications
###end p 42
###begin p 43
n.s., not significant.
###end p 43
###begin p 44
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P < 0.05.
###end p 44
###begin p 45
Baseline parameters in subgroups with diabetic nephropathy
###end p 45
###begin p 46
n.a., data not available.
###end p 46
###begin p 47
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
We then correlated clinical parameters with the expression of TSP-1 and p-smad2/3. Interestingly, beyond the correlation of TSP-1 with the disease stage, the only correlation we detected was present between glomerular p-smad2/3 and the degree of proteinuria (Figure 3C). All other parameters assessed (age, glomerulosclerosis, fibrosis, duration of diabetes, albuminuria, presence of retinopathy, presence of diabetic neuropathy, presence duration of hypertension, HbA1c level, serum creatinine and urea) did not show a direct relationship to TSP-1 or p-smad2/3.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 831 833 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
###xml 1012 1019 1003 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1024 1032 1015 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1095 1100 1086 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13 R14 R15">13&#8211;15</xref>
###xml 1252 1254 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
Type-2 diabetes is one of the most challenging chronic disorders in the western world [1]. After years of diabetes, diabetic nephropathy is very common and associated with excess morbidity and mortality [2]. Despite some improving grasp regarding the underlying pathophysiology, treatment options after the onset of diabetic nephropathy and chronic kidney disease are still very limited. Whereas elevated blood glucose initially causes haemodynamic alterations, hyperfiltration and activation of glomerular cells [3], as well as excessive matrix deposition, are hallmarks of chronic diabetic nephropathy leading to glomerulosclerosis and tubulointerstitial fibrosis of the kidney [4]. TGF-beta is the best-known profibrotic cytokine, clearly being linked to the development of diabetic nephropathy by various experimental studies [17]. To bind to its receptors, latent TGF-beta has to be extracellularly activated. Our group recently demonstrated TSP-1 as an important endogenous activator of latent TGF-beta in in vivo and in vitro models of glomerulonephritis as well as diabetic nephropathy [13-15]. Therefore, interference with the TGF-beta activation process is an interesting therapeutical option to prevent its profibrotic action in the kidney [13].
###end p 49
###begin p 50
###xml 873 874 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 1569 1571 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 1845 1847 1827 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
###xml 1541 1546 <span type="species:ncbi:9606">human</span>
###xml 1720 1728 <span type="species:ncbi:9606">patients</span>
In the present biopsy study, we wanted to investigate the relevance of the TSP-1/TGF-beta axis in human biopsies with type-2 diabetic nephropathy. Dependent on the severity of glomerular and tubulointerstitial lesions, the local nephropathologist divided biopsies into three stages (1-3) of diabetic nephropathy. Glomerular TSP-1 was increased in biopsies with diabetic nephropathy, which was most prominent in advanced disease in areas of glomerulosclerosis and fibrosis (stage 3). In parallel to this finding, we also detected increased expression of TGF-beta and of the number of cells positive for the phosphorylated form of the TGF-beta signalling complex smad2/3 in glomeruli of patients with diabetic nephropathy compared to controls. TSP-1 and p-smad2/3 were co-localized by fluorescence double staining suggesting the experimentally shown functional relationship [8]. Nevertheless, the degree of glomerular TSP-1 did not directly correlate with the extent of glomerular p-smad2/3 positivity, but did significantly correlate with tubulointerstitial smad2/3 positivity. Although pure speculation, this interesting link of glomerular TSP-1 with tubulointerstitial TGF-beta activation may indicate a paracrine action of TSP-1 between different compartments of the kidney. Expression analysis of glomerular TSP-1 as well as TGF-beta and connective tissue growth factor (CTGF) has been performed in a recent study by Wahab and colleagues demonstrating in 19 biopsies that glomerular TSP-1, TGF-beta and CTGF are increased early on during human diabetic nephropathy [12]. Our findings in 40 renal biopsies are consistent with their data, showing increased glomerular TSP-1 already in incipient diabetic lesions of our patients and a more pronounced increase in more severe diabetic disease. While this excellent study by Wahab and co-workers [12] focused completely on glomerular changes, our study also accounts for changes of the tubulointerstitium.
###end p 50
###begin p 51
###xml 603 605 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 699 704 693 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19 R20">19,20</xref>
###xml 1002 1004 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 1080 1085 <span type="species:ncbi:9606">human</span>
Hereby, we could demonstrate that cortical (reflecting tubulointerstitial) TSP-1 was increased during diabetic nephropathy and frequently co-localized with p-smad2/3 positivity indicating TGF-beta signalling activity. In addition, cortical TSP-1 correlated with the number of tubulointerstitial p-smad2/3 positive cells supporting the concept of a causal relationship between TSP-1 and TGF-beta activity in human diabetic nephropathy. The importance of tubulointerstitial changes for the overall time course and progression of human renal disease was established many years ago by Bohle and co-workers [18], while more recent studies confirmed this also for the time course of diabetic nephropathy [19,20]. Our group recently demonstrated in three different experimental nephritis models with interstitial fibrosis that TSP-1 co-localized with active TGF-beta within the tubulointerstitium and was an excellent predictor for the later resulting interstitial fibrosis as detected in individual animals [21]. Therefore, the results of this study suggest a similar role for TSP-1 in human diabetic nephropathy.
###end p 51
###begin p 52
###xml 504 509 498 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22 R23 R24">22&#8211;24</xref>
###xml 887 894 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
In addition, correlating a large number of clinical parameters with the degree of glomerular p-smad2/3 positivity or TSP-1, only the extent of glomerular p-smad2/3 positivity positively correlated with the degree of proteinuria but no other clinical parameter as assessed in these diabetic patients. This interesting finding is consistent with the reported direct relationship between urinary excretion of TGF-beta and proteinuria as well as TGF-beta and glycaemic control, at least early on in disease [22-24]. While we detected a spatial and correlative relation between TSP-1 and the TGF-beta activation, we did not find a correlation of either factors with fibrosis/sclerosis in our biopsies from patients with diabetic nephropathy. While this seems to be a surprising result, it has to be considered that detection of the profibrotic TGF-beta activity might indicate/reflect active de novo production of matrix molecules in a dynamic process but not necessarily the general status of fibrosis, especially when a given tissue is already quite fibrotic/sclerotic. In our study, frequent acellular Kimmelstiel-Wilson lesions, the degree of fibrosis/sclerosis within these biopsies as well as the clinical data indicate mostly severe disease, where the active component of matrix production may actually already be slowed down.
###end p 52
###begin p 53
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 489 494 <span type="species:ncbi:9606">human</span>
In summary, the present study demonstrates the spatial and suggests a functional activity of the TSP-1/TGF-beta axis in patients with type-2 diabetic nephropathy. Especially in the tubulointerstitium of diabetic nephropathy, TSP-1 is closely linked to TGF-beta activity as indicated by p-smad2/3 positivity. The positive correlation of glomerular p-smad2/3 positivity with proteinuria further supports the importance of the TSP-1/TGF-beta system as a relevant mechanism for progression of human type-2 diabetic nephropathy.
###end p 53
###begin p 54
The skilled technical help of S. Weber is gratefully acknowledged. This work was supported by a grant from the Deutsche Forschungsgemeinschaft SFB 423 (TP B6) to C.H.
###end p 54
###begin p 55
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions
###end article-title 57
###begin article-title 58
Diabetic nephropathy in type II diabetes
###end article-title 58
###begin article-title 59
Molecular mechanisms of diabetic renal hypertrophy
###end article-title 59
###begin article-title 60
Cellular and molecular mechanisms of proteinuria in diabetic nephropathy
###end article-title 60
###begin article-title 61
Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up
###end article-title 61
###begin article-title 62
Transforming growth factor-beta in renal disease
###end article-title 62
###begin article-title 63
###xml 43 48 <span type="species:ncbi:9606">human</span>
Role of transforming growth factor beta in human disease
###end article-title 63
###begin article-title 64
Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology
###end article-title 64
###begin article-title 65
Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1
###end article-title 65
###begin article-title 66
Thrombospondins as matricellular modulators of cell function
###end article-title 66
###begin article-title 67
The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta
###end article-title 67
###begin article-title 68
Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli
###end article-title 68
###begin article-title 69
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo
###end article-title 69
###begin article-title 70
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo
###end article-title 70
###begin article-title 71
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo
###end article-title 71
###begin article-title 72
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus
###end article-title 72
###begin article-title 73
TGF-beta in renal injury and disease
###end article-title 73
###begin article-title 74
The role of the interstitium of the renal cortex in renal disease
###end article-title 74
###begin article-title 75
Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy
###end article-title 75
###begin article-title 76
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
###end article-title 76
###begin article-title 77
###xml 115 118 <span type="species:ncbi:10116">rat</span>
Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat
###end article-title 77
###begin article-title 78
Urinary transforming growth factor-beta 1 in various types of nephropathy
###end article-title 78
###begin article-title 79
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Urinary transforming growth factor-beta in patients with diabetic nephropathy: implications for the pathogenesis of tubulointerstitial pathology
###end article-title 79
###begin article-title 80
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Increased renal production of transforming growth factor-beta1 in patients with type II diabetes
###end article-title 80

